Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.040 | 2.040 | 0.000 |
Stocks | 87.100 | 87.100 | 0.000 |
Other | 10.860 | 10.860 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.309 | 23.853 |
Price to Book | 9.339 | 4.498 |
Price to Sales | 4.870 | 3.285 |
Price to Cash Flow | 21.794 | 15.806 |
Dividend Yield | 1.451 | 1.252 |
5 Years Earnings Growth | 9.410 | 12.536 |
Name | Net % | Category Average |
---|---|---|
Consumer Defensive | 33.820 | 7.977 |
Healthcare | 32.370 | 16.378 |
Consumer Cyclical | 10.680 | 12.523 |
Technology | 10.050 | 26.602 |
Financial Services | 6.760 | 13.514 |
Industrials | 6.330 | 11.875 |
Number of long holdings: 25
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk A/S Class B | DK0060534915 | 5.14 | - | - | |
L'Oreal | FR0000120321 | 5.06 | 451.75 | +0.08% | |
Microsoft | US5949181045 | 4.79 | 432.68 | +1.12% | |
Church&Dwight | US1713401024 | 4.77 | 107.93 | +0.19% | |
McCormick&Co | US5797802064 | 4.70 | 69.20 | +1.60% | |
J&J | US4781601046 | 4.29 | 146.76 | -0.25% | |
P&G | US7427181091 | 4.21 | 167.48 | +0.08% | |
Visa A | US92826C8394 | 4.09 | 274.67 | -0.13% | |
Stryker | US8636671013 | 4.07 | 346.40 | -0.51% | |
ADP | US0530151036 | 4.06 | 246.58 | -0.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity R Inc | 17.58M | 6.56 | 5.45 | 14.49 | ||
Fundsmith Equity T Acc | 4.19B | 6.78 | 5.98 | 15.08 | ||
Fundsmith Equity T Inc | 269.49M | 6.78 | 5.98 | 15.08 | ||
Fundsmith Equity I Acc | 15.46B | 6.83 | 6.09 | 15.20 | ||
Fundsmith Equity I Inc | 4.62B | 6.83 | 6.09 | 15.19 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review